Mostrando ítems 1-1 de 1
Moles Fernández, Alejandro (Fecha de defensa: 2022-01-31)
Patients with hereditary breast and ovarian cancer (HBOC) in whom a causative pathogenic variant is not identified after genetic analysis may not benefit from prevention, early detection, or precision treatment measures. ...